Over 11,000 children in the United States are diagnosed with cancer each year. Furthermore, cancer is a leading cause of death, worldwide, causing nearly 1 in 6 deaths in 2020.
New integrated treatments are being utilized to help combat cancer and its disease progression. Hyperbaric therapy is currently being utilized in conjunction with conventional treatments, including radiation and chemotherapy, to attain optimal dosages for patients, stimulate tumour regression and reduce the side effects of treatments.
Cancer thrives in hypoxic environments and hyperbaric therapy has been shown to increase these oxygen levels to weaken tumours and reduce their aggressiveness.
Studies have demonstrated the benefits of hyperbarics as it relates to pediatric cancer, including:
Reducing the side effects of chemotherapy and radiation treatments
Accelerating post-operative healing and preventing infections
Reducing tumor volume, weakening hypoxic tumors and targeting metastatic tumors
Enhancing memory and mental performance, reducing “chemo-brain syndrome” symptoms